A review of the infectious diseases literature from the previous two weeks.
Infectious Disease Puscast
Claim This Podcastby Vincent Racaniello
4.8(126 reviews)
107 episodes
Updated Daily
Accepts GuestsHas SponsorsLocation 🇺🇸
63
Podcast Authority
BetaGoodBased on show quality, social media presence, reviews, charts, and more
Quality88
Social0
YouTube0
Engagement99
Podcast Overview
A review of the infectious diseases literature from the previous two weeks.
Language
🇺🇲
Publishing Since
5/5/2022
Unlock The Full Podcast Authority Score Report
See how your podcast performs across key metrics
63
Podcast Authority
BetaGoodBased on show quality, social media presence, reviews, charts, and more
Quality88
Social0
YouTube0
Engagement99
8
Excellent Areas
4
Good Performance
7
Growth Opportunities
excellent
Episode Length
38 minutes
Performing excellently!
good
Publishing Consistency
Every 14 days
Recommendations available
Unlock the full report to see detailed tips
poor
Episode Thumbnails
Recommendations available
Unlock the full report to see detailed tips
+16 More Metrics
Unlock comprehensive insights including:
- • YouTube presence analysis
- • Social media reach metrics
- • RSS compliance scoring
- • Podcast 2.0 features
- • Technical standards
What's Included in Your Full Report
Detailed Analytics
- Complete breakdown of all 19 authority metrics
- Personalized recommendations for each metric
- Industry benchmarks and comparisons
- Technical RSS feed analysis and compliance scoring
Growth Strategies
- Step-by-step action plans for improvement
- Quick wins to boost your score immediately
- Pro tips from successful podcasters
Get your free podcast insights report
See how your show performs across every key metric
Instant delivery
No spam
Attract Better Guests
High authority scores make your podcast more attractive to industry leaders and influencers who want to appear on credible shows.
Secure Sponsorships
Sponsors look for podcasts with proven authority and engagement. Your score demonstrates your podcast's value to potential partners.
Grow Your Audience
Understanding your strengths and weaknesses helps you make data-driven decisions to expand your listener base effectively.
1 verified contact email on file for Infectious Disease Puscast
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes
May 29, 2026
Infectious Disease Puscast #107
Host Daniel Griffin and guest Sarah Dong review recent infectious disease literature, covering breakthroughs in Hepatitis Delta and Hantavirus outbreaks.
May 13, 2026
Infectious Disease Puscast #106
<p>On episode #106 of the Infectious Disease Puscast, Daniel and Sara review the infectious disease literature for the weeks of 4/23 – 5/6/26.</p> <div class="fluid-width-video-wrapper">Host: <a title="" href= "http://www.parasiteswithoutborders.com/"><strong>Daniel Griffin</strong></a> and <a title="" href= "https://febrilepodcast.com/"><strong>Sarah Dong</strong></a></div> <p>Subscribe (free): <strong><a href= "https://podcasts.apple.com/us/podcast/infectious-disease-podcast/id1622649470">Apple Podcasts</a>, <a href= "https://feeds.libsyn.com/413927/rss">RSS</a></strong>, email</p> <p>Become a <a href= "https://www.microbe.tv/contribute">patron</a> of Puscast!</p> <h3 id="links-for-this-episode" class="wp-block-heading"> <strong>Links for this episode</strong></h3> <ul class="wp-block-list"> <li><strong>Viral</strong></li> <li><a href= "https://www.ecdc.europa.eu/en/infectious-disease-topics/hantavirus-infection/surveillance-and-updates/andes-hantavirus-outbreak"> <strong>Andes hantavirus</strong></a> outbreak in cruise ship, 11 May 2026<strong>(</strong>European Centre for Disease Prevention and Control)</li> <li>2026 Multi-country <a href= "https://www.cdc.gov/han/php/notices/han00528.html?ACSTrackingID=DM155095&ACSTrackingLabel=HAN%20528%20-%20Health%20Advisory%20(for%20COCA%20partners)&deliveryName=DM155095"><strong>Hantavirus Cluster</strong></a> Linked to Cruise Ship (CDC: Health Alert Network)</li> <li><a href= "https://www.nejm.org/doi/full/10.1056/NEJMoa2009040"><strong>"Super-Spreaders"</strong></a> and Person-to-Person Transmission of Andes Virus in Argentina (NEJM)</li> <li>Infectious Diseases Society of America (IDSA) Position Statement: Why <a href= "https://academic.oup.com/cid/article/82/4/622/8364653?utm_source=etoc&utm_campaign=cid&utm_medium=email&nbd=13518097993&nbd_source=campaigner"><strong>IDSA Did Not Endorse</strong></a> the Community-Acquired Pneumonia Guidelines 2025 Update (CID)</li> <li><a href= "https://academic.oup.com/cid/article/82/4/625/8364680?utm_source=etoc&utm_campaign=cid&utm_medium=email&nbd=13518097993&nbd_source=campaigner"> <strong>We Dissent:</strong></a> Lessons From the 2025 Community-Acquired Pneumonia Guidelines (CID)</li> <li>Central Nervous System Involvement by <a href= "https://academic.oup.com/ofid/advance-article/doi/10.1093/ofid/ofag283/8671929"><strong>Novel Clade 2.3.2.1e H5N1</strong></a> Avian Influenza Virus in a Paediatric Patient (OFID)</li> <li>Impact of Respiratory Syncytial Virus <a href= "https://academic.oup.com/cid/article-abstract/82/4/658/8280078?redirectedFrom=fulltext&utm_source=etoc&utm_campaign=cid&utm_medium=email&nbd_source=campaigner&nbd=13518097993"><strong>Immunization</strong></a> on the Rate of Pediatric Acute Otitis Media: A Time-series Analysis (CID)</li> <li><strong>Bacterial</strong></li> <li>Performance of a <a href= "https://www.clinicalmicrobiologyandinfection.org/article/S1198-743X(26)00208-9/abstract?dgcid=raven_jbs_aip_email"><strong>rapid, visual fingerstick serology self-test</strong></a> for Helicobacter pylori detection and typing: A prospective multicenter diagnostic accuracy study (CMI: Clinical Microbiology and Infection)</li> <li>Real-world effectiveness of <a href= "https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(26)00115-5/abstract?dgcid=raven_jbs_aip_email"><strong>20-valent pneumococcal conjugate vaccine</strong></a> against all-cause outcomes among Medicare beneficiaries aged 65 years and older in the USA: a retrospective cohort study (LANCET: Infectious Diseases)</li> <li>Beta-Lactam plus Azithromycin or Doxycycline versus Fluoroquinolones in <a href= "https://academic.oup.com/ofid/advance-article/doi/10.1093/ofid/ofag253/8665981?utm_source=advanceaccess&utm_campaign=ofid&utm_medium=email"><strong>Hospitalized Adult</strong></a> Patients with Community-Acquired Pneumonia: A Systematic Review and Network Meta-Analysis (OFID)</li> <li><a href= "https://www.clinicalmicrobiologyandinfection.org/article/S1198-743X(26)00213-2/fulltext?dgcid=raven_jbs_aip_email"> <strong>Syphilis</strong></a> and the risk of stroke: a nationwide, population-based matched cohort study (CMI: Clinical Microbiology and Infection)</li> <li>Reducing Bacterial Contamination of Blood Bags with a <a href= "https://www.nejm.org/doi/full/10.1056/NEJMc2600589"><strong>Double Knot</strong></a> (NEJM)</li> <li>Effectiveness and safety of daptomycin versus vancomycin in <a href= "https://www.clinicalmicrobiologyandinfection.org/article/S1198-743X(26)00215-6/abstract?dgcid=raven_jbs_aip_email"><strong>methicillin-resistant Staphylococci left-side infective endocarditis</strong></a>. Results from a nationwide prospective multicenter cohort. (CMI: Clinical Microbiology and Infection)</li> <li><strong>Fungal</strong></li> <li><a href= "https://www.youtube.com/watch?v=48WJNnNefvI"><strong>The Last of US Season 2</strong></a> (YouTube)</li> <li><a href= "https://link.springer.com/article/10.1007/s40121-026-01342-3"><strong> Non-intravenous Amphotericin B</strong></a>: A Review of Localized Administration Routes (Infectious Diseases and Therapy)</li> <li><strong>Parasitic</strong></li> <li>Duration and association with protection of <a href= "https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(26)00081-2/fulltext?dgcid=raven_jbs_aip_email"><strong>NANP-repeat-specific</strong></a> and C-terminus-specific anti-circumsporozoite protein IgG responses following RTS,S/AS01<sub>E</sub> vaccination: an observational ancillary immunological study of a phase 3 clinical trial (LANCET: Infectious Diseases)</li> <li>Combined Oral Ivermectin and 5% Permethrin Cream to Treat <a href= "https://www.nejm.org/doi/full/10.1056/NEJMoa2411721?query=TOC&cid=DM2448625_NEJM_Non_Subscriber&bid=-807896993"><strong>Severe Scabies</strong></a> (NEJM)</li> <li><strong>Miscellaneous</strong></li> <li><a href= "https://academic.oup.com/cid/advance-article-abstract/doi/10.1093/cid/ciag152/8664683?redirectedFrom=fulltext"> <strong>Interest in Infectious Diseases</strong></a> Among Internal Medicine Resident Physicians: Results From a Nationwide Survey (CID)</li> </ul> <p>Music is by <a href= "http://www.ronaldjenkees.com/"><strong>Ronald Jenkees</strong></a></p> <p>Information on this podcast should not be considered as medical advice.</p>
April 28, 2026
Infectious Disease Puscast #105
<p>On episode #105 of the Infectious Disease Puscast, Daniel and Sara review the infectious disease literature for the weeks of 4/9 – 4/22/26.</p> <div class="fluid-width-video-wrapper">Host: <a title="" href= "http://www.parasiteswithoutborders.com/"><strong>Daniel Griffin</strong></a> and <a title="" href= "https://febrilepodcast.com/"><strong>Sarah Dong</strong></a></div> <p>Subscribe (free): <strong><a href= "https://podcasts.apple.com/us/podcast/infectious-disease-podcast/id1622649470"> Apple Podcasts</a>, <a href= "https://feeds.libsyn.com/413927/rss">RSS</a></strong>, email</p> <p>Become a <a href= "https://www.microbe.tv/contribute">patron</a> of Puscast!</p> <h3 id="links-for-this-episode" class="wp-block-heading"> <strong>Links for this episode</strong></h3> <ul class="wp-block-list"> <li><strong>Viral</strong></li> <li>Oral Nirmatrelvir–Ritonavir for Covid-19 in <a href= "https://www.nejm.org/doi/full/10.1056/NEJMoa2502457"><strong>Higher-Risk</strong></a> Outpatients (NEJM)</li> <li>Same Pill, <a href= "https://www.nejm.org/doi/full/10.1056/NEJMe2603127"><strong>Different Impact</strong></a> — Reassessing the Efficacy of Nirmatrelvir–Ritonavir (NEJM)</li> <li>Paxlovid <a href= "https://www.cidrap.umn.edu/covid-19/paxlovid-doesn-t-reduce-hospitalization-death-rates-vaccinated-high-risk-covid-outpatients"><strong>doesn't reduce</strong></a> hospitalization, death rates in vaccinated high-risk COVID outpatients, trial shows (CIDRAP)</li> <li>Risk of <a href= "https://www.nejm.org/doi/full/10.1056/NEJMc2519008?query=TOC"><strong>Guillain–Barré Syndrome</strong></a> after Laboratory-Confirmed Dengue Infection (NEJM)</li> <li>A New Type of <a href= "https://academic.oup.com/jid/advance-article-abstract/doi/10.1093/infdis/jiag171/8661120?redirectedFrom=fulltext&login=true"><strong>Nonsuppressible</strong></a> Viremia Produced by HIV-Infected Macrophage (JID)</li> <li><a href= "https://academic.oup.com/jid/advance-article/doi/10.1093/infdis/jiag213/8658894?utm_source=advanceaccess&utm_campaign=jid&utm_medium=email"> <strong>First Report</strong></a> on Remdesivir Use for the Treatment of Respiratory Syncytial Virus in Five Allogeneic Hematopoietic Cell Transplant Recipients (JID)</li> <li><strong>Bacterial</strong></li> <li><a href= "https://www.cdc.gov/mmwr/volumes/75/ss/ss7501a1.htm?s_cid=OS_ss7501a1_e&ACSTrackingID=USCDC_921-DM154268&ACSTrackingLabel=MMWR%20Surveillance%20Summaries%20%E2%80%93%20Vol.%2075%2C%20April%2016%2C%202026&deliveryName=USCDC_921-DM154268"> <strong>Tetanus</strong></a> Surveillance — United States, 2009–2023 (CDC: MMWR)</li> <li>Notes from the Field: <a href= "https://www.cdc.gov/mmwr/volumes/75/wr/mm7514a2.htm?s_cid=OS_mm7514a2_e&ACSTrackingID=USCDC_921-DM154395&ACSTrackingLabel=Week%20in%20MMWR%3A%20Vol.%2075%2C%20April%2016%2C%202026&deliveryName=USCDC_921-DM154395"><strong>Tetanus in Four Children</strong></a> — Idaho, Minnesota, Missouri, and Wisconsin, 2024 (CDC: MMWR)</li> <li>Amoxicillin-Clavulanate <a href= "https://jamanetwork.com/journals/jama/article-abstract/2847972"><strong>vs</strong></a> Amoxicillin for Acute Sinusitis in Adults (JAMA)</li> <li>Efficacy and safety of <a href= "https://link.springer.com/article/10.1007/s15010-026-02745-7#xd_co_f=YjE1NzdjMGEtNzM0My00MjI2LWJhYzYtNjA3NzkzODNiNDRl~"><strong>vancomycin</strong></a> versus 13 alternatives in MRSA-confirmed skin and soft tissue infections: a meta-analysis of 39 randomized controlled trials (Infection)</li> <li><a href= "https://academic.oup.com/ofid/advance-article/doi/10.1093/ofid/ofag221/8654584?utm_source=advanceaccess&utm_campaign=ofid&utm_medium=email"> <strong>Methicillin-Resistant Staph Aureus</strong></a> (MRSA) Nasal Swab Utilization as a Predictor for MRSA Skin & Soft Tissue Infections: A Systematic Review and Meta-analysis (OFID)</li> <li>Practice variation, outcomes and definitions of suppressive antimicrobial therapy for prosthetic <a href= "https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciag251/8653227?utm_source=advanceaccess&utm_campaign=cid&utm_medium=email"><strong>joint infections</strong></a>: a systematic review and expert consensus statement (CIC)</li> <li>Efficacy and safety of <a href= "https://www.bmj.com/content/393/bmj-2025-085716"><strong>VPM1002 and Immuvac</strong></a><strong>in</strong> preventing tuberculosis: phase 3 randomised clinical trial (PreVenTB trial) (BMJ)</li> <li>Comparison of <a href= "https://academic.oup.com/cid/advance-article-abstract/doi/10.1093/cid/ciag194/8526631?redirectedFrom=fulltext"><strong>Ceftolozane-Tazobactam and Ceftazidime-Avibactam</strong></a> in the Treatment of Multidrug-Resistant/Difficult-to-Treat Resistant Pseudomonas aeruginosa Infections: A Systematic Review and Meta-analysis (CID)</li> <li>Do C-Reactive Protein Measurements Predict <a href= "https://academic.oup.com/ofid/advance-article/doi/10.1093/ofid/ofag239/8660529"><strong>Treatment Failure</strong></a> in Native Vertebral Osteomyelitis? (OFID)</li> <li><strong>Fungal</strong></li> <li><a href= "https://www.youtube.com/watch?v=48WJNnNefvI"><strong>The Last of US Season 2</strong></a> (YouTube)</li> <li>Rising burden of <a href= "https://academic.oup.com/jpids/article/15/4/piag019/8516503"><strong>severe pediatric coccidioidomycosis</strong></a>: a 25-year single-center study (Journal of the Pediatric Infectious Diseases Society)</li> <li><a href= "https://academic.oup.com/cid/advance-article-abstract/doi/10.1093/cid/ciag252/8653119"> <strong>Candida glabrata</strong> </a>emerges as the most common cause of candidemia: analysis of a large hospital-based database, United States, 2016–2024 (CID)</li> <li>Test Performance and Clinical Utility of the <a href= "https://academic.oup.com/ofid/advance-article/doi/10.1093/ofid/ofag198/8644214?utm_source=advanceaccess&utm_campaign=ofid&utm_medium=email"><strong>cobas<sup>®</sup> eplex</strong></a> Blood Culture Identification Fungal Pathogen Panel (OFID)</li> <li><a href= "https://wwwnc.cdc.gov/eid/article/32/3/25-1042_article"><strong>Cutaneous Paraconiothyrium cyclothyrioides</strong> </a>Infection in Lung Transplant Recipient, Georgia, USA (Emerging Infectious Diseases)</li> <li><a href= "https://academic.oup.com/ofid/article/13/4/ofag150/8659480?utm_source=advanceaccess&utm_campaign=ofid&utm_medium=email"> <strong>Azole Resistance</strong></a> in Aspergillus fumigatus From Diverse Environments in Ohio, United States, Is Primarily Driven by TR<sub>34</sub>/L98H and TR<sub>46</sub>/Y121F/T289A Environmental Signatures (OFID)</li> <li><strong>Parasitic</strong></li> <li>Fatal Donor-Derived Disseminated <a href= "https://academic.oup.com/ofid/article/13/4/ofag158/8651136?utm_source=advanceaccess&utm_campaign=ofid&utm_medium=email"><strong>Acanthamoeba</strong></a> Infection in a Liver Transplant Recipient (OFID)</li> <li><strong>Miscellaneous</strong></li> <li>Host–microbiome archetypes differentiate infection from <a href= "https://www.nature.com/articles/s41467-026-71863-5"><strong>pathogen carriage</strong></a> in the human lower airway (Nature Communications)</li> </ul> <p>Music is by <a href= "http://www.ronaldjenkees.com/"><strong>Ronald Jenkees</strong></a></p> <p>Information on this podcast should not be considered as medical advice.</p>
107 total episodes available with 3 transcripts
Similar Podcasts
Discover related shows you might enjoy
Febrile
Sara Dong
This Week in Virology
Vincent Racaniello
This Week in Microbiology
Vincent Racaniello
Immune
Vincent Racaniello
This Week in Virology
Vincent Racaniello
Breakpoints
Society of Infectious Diseases Pharmacists
This Week in Parasitism
Vincent Racaniello
Let's Talk ID
Infectious Diseases Society of America (IDSA)
ID:IOTS - Infectious Disease Insight Of Two Specialists
Infectious Disease: Insights of Two Specialists
The Curious Clinicians
The Curious Clinicians
The Clinical Problem Solvers
The Clinical Problem Solvers
Core IM | Internal Medicine Podcast
Core IM Team
Annals On Call Podcast
American College of Physicians
Communicable
CMI Communications
Harrison's PodClass: Internal Medicine Cases and Board Prep
AccessMedicine
Deep-dive analytics for Infectious Disease Puscast
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is Infectious Disease Puscast?
- How often does this podcast release new episodes?
This podcast updates daily.
- Where can I listen to this podcast?
This podcast is available on 8 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Yes, this podcast regularly features guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.